Scientists Conclude Pertussis Vaccine (DPT) Causes Permanent Brain Damage
A Fact from 1989 That Did Not Make Main Stream Media
“This workshop brought together 19 of the finest basic science researchers and medical specialists in the world. Their unanimous agreement that toxins in the B. pertussis bacteria definitely have the capability of causing permanent brain damage both during the course of the disease and after vaccination is a validation of what parents in our organization have been maintaining for eight years. Health officials in the government and the American Academy of Pediatrics, who maintain the vaccine does not cause permanent brain damage, are deliberately ignoring the evidence.”
Although the majority of seizures following pertussis vaccination are associated with fever, it was the consensus of the neurologists attending the workshop, that these do not represent febrile convulsions, but are non-benign convulsions.
The scientists also concluded that the convulsions which accompany severe cases of whooping cough and which follow vaccination are not solely caused by fever but are likely to be due to the combined effects of pertussis toxin and endotoxin. They also agreed that, although the vaccine may accelerate neurologic signs in some children with an underlying neurologic disorder, in many others no pre-existing brain abnormality exists. The scientists supported the replacement of the current whole-cell vaccine with less toxic acellular or genetically engineered pertussis vaccines.
In 1989 Scientists Conclude Pertussis Vaccine Causes Permanent Brain Damage
The National Vaccine Information Center sponsored an international Workshop on The Neurological Complications of Pertussis and the Pertussis Vaccine. September 28 – October 1, 1989
The scientists attending concluded that both whooping cough and the current whole-cell pertussis vaccine can cause permanent brain damage ranging from learning disabilities to severe retardation and seizure disorders.
Nineteen of the leading science researchers and medical specialists unanimously agreed that toxins in the B. pertussis bacteria have the capability of causing permanent brain damage.
In evaluating side-reactions to the vaccine, the following must be kept in mind:
1. Vaccines are not standardized between manufacturers.
2. For a given manufacturer, vaccines are not standard from one batch to the next.
3. Unless the vaccine is properly prepared and refrigerated, its potency and reactivity varies with shelf life.
In fact, the whole question of vaccine detoxification has never been systematically investigated.
Risks of a vaccine reaction – From the CDC website 2019
INFANRIX (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed)
- Redness, soreness, swelling, and tenderness where the shot is given are common after DTaP.
- Fever, fussiness, tiredness, poor appetite, and vomiting sometimes happen 1 to 3 days after DTaP vaccination.
- More serious reactions, such as seizures, non-stop crying for 3 hours or more, or high fever (over 105°F) after DTaP vaccination happen much less often. Rarely, the vaccine is followed by swelling of the entire arm or leg, especially in older children when they receive their fourth or fifth dose.
- Long-term seizures, coma, lowered consciousness, or permanent brain damage happens extremely rarely after DTaP vaccination. (Why don’t they say how often, we add?)
As with any medicine, there is a very remote chance of a vaccine causing a severe allergic reaction, another serious injury, or death.
CONTRAINDICATIONS
Hypersensitivity
Severe allergic reaction (e.g., anaphylaxis) after a previous dose of any diphtheria toxoid-, tetanus toxoid-, or pertussis- containing vaccine, or to any component of INFANRIX is a contraindication [see Description (11)]. Because of the uncertainty as to which component of the vaccine might be responsible, no further vaccination with any of these components should be given. Alternatively, such individuals may be referred to an allergist for evaluation if immunization with any of these components is being considered.Encephalopathy
Encephalopathy (e.g., coma, decreased level of consciousness, prolonged seizures) within 7 days of administration of a previous dose of a pertussis-containing vaccine that is not attributable to another identifiable cause is a contraindication to administration of any pertussis-containing vaccine, including INFANRIX.
Side Effects
From the Package Insert 2019
Postmarketing Experience:
In addition to reports in clinical trials, worldwide voluntary reports of adverse events received for INFANRIX since market introduction are listed below. This list includes serious events and events that have a plausible causal connection to INFANRIX. These adverse events were reported voluntarily from a population of uncertain size; therefore, it is not always possible to reliably estimate their frequency or establish a causal relationship to vaccination.
Infections and Infestations: Bronchitis, cellulitis, respiratory tract infection.
Blood and Lymphatic System Disorders: Lymphadenopathy, thrombocytopenia.
Immune System Disorders: Anaphylactic reaction, hypersensitivity.
Nervous System Disorders: Encephalopathy, headache, hypotonia, syncope.
Ear and Labyrinth Disorders: Ear pain
Cardiac Disorders: Cyanosis.
Respiratory, Thoracic, and Mediastinal Disorders: Apnea, cough.
Skin and Subcutaneous Tissue Disorders: Angioedema, erythema, pruritus, rash, urticaria.
General Disorders and Administration Site Conditions:
Fatigue, injection site induration, injection site reaction, Sudden Infant Death Syndrome.
Postmarketing Experience KINRIX
KINRIX (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated 179 Poliovirus Vaccine) is a noninfectious, sterile vaccine for intramuscular administration.
Nervous System Disorders: Syncope.
Skin and Subcutaneous Tissue Disorders: Pruritus.
Additional adverse events reported following postmarketing use of INFANRIX, for which a causal relationship to vaccination is plausible, are: Allergic reactions, including anaphylactoid reactions, anaphylaxis, angioedema, and urticaria; apnea; collapse or shock-like state (hypotonic153 hyporesponsive episode); convulsions (with or without fever); lymphadenopathy; and thrombocytopenia.
Quadracel – FDA Approved 2015
(Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated 161 Poliovirus Vaccine) is a sterile suspension for intramuscular injection.
Quadracel™ 6.2 Postmarketing Experience
The following adverse events have been spontaneously reported, during the post-marketing
use of Quadracel outside the US, in infants and children from 2 months through 6 years of age.
Because these events are reported voluntarily from a population of uncertain size, it is not
possible to estimate their frequency reliably or establish a causal relationship to vaccine
exposure. This list includes adverse events based on one or more of the following factors:
severity, frequency of reporting, or strength of evidence for a causal relationship to Quadracel.
Immune system disorders
Anaphylactic reaction, hypersensitivity and allergic reactions (such as rash, urticaria,
dyspnea)
Sanofi Pasteur Full Prescribing Information
– Quadracel™
Page 9 of 21
Psychiatric disorders
Screaming
Nervous system disorders
Somnolence, convulsion, febrile convulsion, HHE, hypotonia
Cardiac disorders
Cyanosis
Vascular disorders
Pallor
General disorders and administration site conditions
Listlessness
Injection site reactions (including inflammation, mass, sterile abscess, and edema)
Large injection site reactions (>50 mm), including limb swelling which may extend from
the injection site beyond one or both joints6 Infections and Infestations
Injection site cellulitis, injection site abscess
Quadracel™
It is recommended for pregnant women because studies show that the child receives some protection, “borrowed immunity” to the disease.
YET: The Package Insert States
Pregnancy Category C
Animal reproduction studies have not been conducted with Quadracel. It is also not known whether Quadracel can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity.
Somnolence – Strong desire for sleep
Hypotonia – Abnormal level of muscle tone
Urticaria – Hives
HHE – Hypotonic-Hyporesponsive Episode – A hypotonic-hyporesponsive episode is defined as sudden onset of poor muscle tone, reduced consciousness, and pale or bluish skin.
Cyanosis – Bluish skin from inadequate oxygenation of the blood or poor circulation.
Dyspepsia – Breathing difficulties
Encephalopathy – A general term that means brain disease, damage, or malfunction.
Hypotonia – Decreased muscle tone
The safety and effectiveness of this vaccine have not been established in pregnant women. Animal reproduction studies have not been conducted with this vaccine. It is also not known whether this vaccine can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. This vaccine should be given to a pregnant woman only if clearly needed.
SEPTEMBER 20, 2018
Request for Office of Inspector General to Investigate Fraud and Obstruction of Justice
Re: Request for investigation of fraud and obstruction of justice by HHS and the United States Department of Justice officials that deprived over 5400 children of compensation for their vaccine injuries in the Omnibus Autism Proceeding.
This fraud and obstruction of justice in the Vaccine Injury Compensation Program influenced and corrupted the decision by the Supreme Court of the United States in Bruesewitz v. Wyeth which further deprived all families nationwide of their ability to pursue vaccine injury cases in civil courts.